DTx WEST 2023
6TH ANNUAL

DTx WEST 2023

February 22 - 24, 2023 | San Mateo, CA

The Meeting Point For The DTx Community

AGENDA CLICK HERE TO REGISTER

2023 Partners

Knowledge Partners
Knowledge Partner

BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Every line of code of our BrightInsight Platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement. The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with global security, privacy and regulatory requirements. Deployed as a managed service, the platform accelerates time to market for biopharma and medtech companies, reduces the cost of implementation and maintenance versus a custom solution, and scales across products and global markets.

Learn More

Knowledge Partner

Curebase is a leading provider of decentralized clinical research software and services for digital therapeutics. Curebase enables any patient and any healthcare provider to be part of a clinical study, accelerating enrollment and enabling novel study designs with diverse populations. Curebase operates as a complete eClinical software platform, virtual research site, and full-service CRO.

Learn More

Knowledge Partner

Decimal.health is a specialized digital health consulting firm that creates and implements
strategies to launch and grow digital health products and services. Through our deep network
and expertise in US healthcare delivery and regulations, we help digital health businesses
navigate the complex DTx and FDA regulatory path and gain traction with investors and
customers

Learn More

Knowledge Partner

Ieso is a data-driven AI healthcare company pioneering next-generation digital therapeutics to improve mental health outcomes and access to care. 

The company is developing a pipeline of AI-driven evidence-based mental health assessment tools and solutions to democratize access to mental health therapy at scale. With a network of more than 600 fully qualified therapists, ieso provides virtual care (or telehealth) serving more than 20 million adults through the UK National Health Service (NHS), delivering more than 460,000 hours of cognitive behavioral therapy (CBT).

The company has analyzed over 500 million datapoints to decode the active ingredients of therapy to develop scalable digital therapeutics. ieso’s research has been published in several peer-reviewed journals including the Lancet and JAMA, shaping our understanding of scalable digital mental healthcare solutions.

Learn More

Knowledge Partner

TopLine Power® is what Simon-Kucher is all about. We help clients grow revenue through optimization of strategy, pricing, marketing, and sales across industries.
We are a thought leader in these topics at the intersection of digitalization and life sciences, positioning our clients to thrive in the healthcare industry of the future.

Learn More

Knowledge Partner

Dawn Health is a leading company in digital health specializing in the development of software as medical device (SaMD) and digital therapeutics (DTx). Partnering with the pharmaceutical industry and leveraging the Dawn Platform, Dawn Health accelerates the launch of digital solutions that improve the lives of people with chronic conditions.

Learn more

Knowledge Partner

Delve Health’s Clinical StudyPal is a multi-modal, end-to-end platform that supports virtual, hybrid, and traditional clinical trials through the collection of passive data from patient data sources like wearables, biosensors, and medical devices will drive innovation within the field.

Clinical StudyPal can integrate into virtually any source system, allowing for real-world data (RWD) to be captured in real-time, as well as automate a study staff’s workflow—significantly decreasing a clinical trial sites burden, while also lowering costs due to boosting efficiency.

We support the digital healthcare movement in order to provide access to diverse and underrepresented patient populations, worldwide. We work with a wide array of companies and organizations, including but not limited to pharmaceutical, general healthcare, clinical research organizations, insurance companies, medical device companies, as well as disease-specific therapeutic areas.

Learn More

Knowledge Partner

We set our sight on a simple, but powerful vision to advance life science services toward a healthier world.

The journey began when Water Street Healthcare Partners and JLL Partners joined forces to acquire and combine the most comprehensive platform of life sciences services in the industry. Together, we are EVERSANA.

We offer more than 500 clients – from start-ups to established global pharmaceutical leaders – the services they need to bring critical therapies to market while improving the lives of patients around the world.

Learn More

Summit Partners
Summit Partner

Curavit is a “Virtual CRO” that designs and executes decentralized – or “virtual” – clinical trials.  Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study; eliminating the need for physical infrastructure and travel, while increasing data quality.  Curavit brings together the world’s leading researchers, enrolls previously untapped and underserved patient populations, applies machine learning algorithms to health and social engagement information to recruit participants, and leverages leading telehealth, patient data, and medical device technologies.  Curavit’s central virtual site supports remote monitoring and is always audit ready.

Learn More

Summit Partner

DTxCC: a boutique consultancy focused solely on Digital Therapeutics and Digital Health commercialization

We specialize in go-to-market strategy development:

– Market Access and  Reimbursement
– Business models development
– Data monetization

Our Payer Advisory Council provides actionable insight

Custom qualitative research
– One-one-one interviews

Advisory board meetings
– Virtual
– Live face-to-face meetings

Learn More

Summit Partner
Supporter
Supporter

Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. are the US-based indirect subsidiaries of the global healthcare company Otsuka Pharmaceutical Co. Ltd with the corporate philosophy: “Otsuka – people creating new products for better health worldwide.” Otsuka’s US companies share a deep commitment to the development and commercialization of innovative products in the spaces of neuroscience, nephrology, and digital medicine. We have an unwavering belief in doing more and going above and beyond – under any circumstances – so that patients can push past the limitations of their disease and achieve more than they thought was possible every day.

Learn more

Key Features
3 DAYS OF LEARNING

DTx West has returned! Bringing you 3 full days of cutting-edge content and an industry leading speaker faculty, this event provides you with a one-stop shop of all things digital therapeutics ensuring you leave the event with key takeaways and the knowledge to accelerate your own digital journey. Come along to DTx West 2023 and get exclusive access to the latest and greatest in digital medicine. We  look forward to seeing you in February!

DTx West Personalized Participation
CAREFULLY CRAFTED AGENDA BUILT AROUND KEY TOPICS

The time has come to meet in-person once again! Join your peers for live presentations and engaging discussions. DTx West will be diving into key areas such as Commercialization, Regulation, Clinical Trials, Patient Insights, Provider Adoption, User Engagement, Partnerships and more. No matter where your interest lies, we’ve got you covered.

SENIOR & MULTIFACETED COMMUNITY

Experts from every stakeholder within the digital therapeutics space will be coming down to California in February 2023. Calling to every corner of the industry, join your peers from leading DTx companiesPharmaPayersProvidersGovernment Bodies, Academia, Policy Makers and more. Step away from the screen for 3 days of industry-defining discussions and catch up with old and make new connections within the field.

“This year DTx has been a great opportunity to interact with thought leaders of the industry, learn from them and establish partnerships with them. I think the education you receive here is really great.”

Steve Losardo, Vice President, Life Science Solutions & Consulting, SoftServe

“DTx East 2022 has been a phenomenal experience, looking forward to DTx West in 2023”

Shaheen Lakhan, Chief Medical Officer, Click Therapeutics

“The digital therapeutics industry as a whole is incredibly collaborative, and the DTx conference series provides the ideal platform for all stakeholders to come together, share ideas, and leave with the ability to have the most impact on patients’ lives”

 

Andy Molnar, Chief Executive Officer, Digital Therapeutics Alliance

“I always find the topics are very clear, concise and topical. You’re really following the conversations that are happening and so a lot of times when I look at the agenda I think ‘these are exactly all the things that I want to talk or hear about’”

Kamal Jethwani, Co-Founder & CEO, Decimal.health

“DTx East was by far the best digital conference I’ve been to”

Jo Masterson, CEO & Co-Founder, 2morrow, Inc.

2023 Speaker Faculty

Shah Nawaz
Shah Nawaz
Chief Technology Officer, VP, Digital Technology
Regeneron
Shah Nawaz
Chief Technology Officer, VP, Digital Technology
Regeneron
Anand Iyer
Anand Iyer
Chief Strategy Officer
Welldoc
Anand Iyer
Chief Strategy Officer
Welldoc

Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®. Since joining WellDoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. He holds an MS and a PhD in electrical and computer engineering, and an MBA from Carnegie Mellon University.

Jennifer Goldsack
Jennifer Goldsack
Chief Executive Officer
Digital Medicine Society
Jennifer Goldsack
Chief Executive Officer
Digital Medicine Society
Edmondo Robinson
Edmondo Robinson
Chief Digital Officer
Moffitt Cancer Center
Edmondo Robinson
Chief Digital Officer
Moffitt Cancer Center

Dr. Robinson leads Moffitt’s Center for Digital Health which
leverages the tools of IT, Health Data Services, and Digital

Innovation to expand Moffitt’s ecosystem to deliver on consumer-
oriented, real-world solutions for clinical practice, research,

education, and administrative processes. The Center for Digital
Health creates and tests new services, programs, partnerships, and
technologies that leverage digital innovations, while challenging the
status quo to reduce the cost of care, improve quality, increase
access to care, and enhance the patient experience. In addition, he
directly cares for Moffitt patients as part of the Internal and Hospital
Medicine Program.
Previously, Dr. Robinson was the Chief Transformation Officer and
Senior Vice President of Consumerism at ChristianaCare, one of the
largest health systems in the mid-Atlantic. He was responsible for
the transformation of health care delivery to advance population
health initiatives and the move from volume-based to value-based
care with a special focus on developing and managing
ChristianaCare’s consumerism and digital strategies.
Dr. Robinson is an associate professor at University of South
Florida’s Morsani College of Medicine. He is also a fellow of the
American College of Physicians and a senior fellow of the Society of
Hospital Medicine. He holds a medical degree from the David
Geffen School of Medicine at the University of California, Los
Angeles; an MBA with an emphasis in health care management from
the Wharton School at the University of Pennsylvania; and a
master’s degree in health policy research also from the University of
Pennsylvania.

Anindita Saha
Anindita Saha
Assistant Director, Digital Health Center of Excellence
FDA
Anindita Saha
Assistant Director, Digital Health Center of Excellence
FDA
John Kraus
John Kraus
Executive Vice President, Chief Medical Officer
Otsuka America Pharmaceutical Inc
John Kraus
Executive Vice President, Chief Medical Officer
Otsuka America Pharmaceutical Inc
Elena Mustatea
Elena Mustatea
Chief Executive Officer & Co-Founder
Bold Health
Elena Mustatea
Chief Executive Officer & Co-Founder
Bold Health
Scott Barclay
Scott Barclay
Managing Director
Insight Partners
Scott Barclay
Managing Director
Insight Partners

Scott Barclay is a Managing Director at Insight Partners, where he focuses on investments in healthtech. His Computational Care thesis envisions the future of US and global healthcare built at the intersection of empathy and scalable technology.

Scott’s early career traversed capital markets with Banc of America Securities in Europe and the US, The Boston Consulting Group, and CVS Health. At CVS and then after, Scott helped create and scale the nation’s e-Prescribing ecosystem, running iScribe (acq Allscripts) and as Chief Strategy Officer of Surescripts.

Prior to Insight, Scott built his investing career as a healthcare angel investor and advisor (NaviHealth, Doximity, Elation) and, from 2015 – 2020, as a Partner at DCVC, a world-class early-stage deep tech venture capital firm, where he was a director or observer on the Boards of companies like Carbon Health, Freenome, SafelyYou, and many others.

Scott holds a BA in History from the University of Virginia and an MBA from INSEAD in Fontainebleau, France.

Jodi Prohofsky
Jodi Prohofsky
Chief Operating Officer
ieso
Jodi Prohofsky
Chief Operating Officer
ieso
David Klonoff
David Klonoff
President | Clinical Professor of Medicine
Diabetes Technology Society | U.C San Francisco
David Klonoff
President | Clinical Professor of Medicine
Diabetes Technology Society | U.C San Francisco
Benjamin Alouf
Benjamin Alouf
Chief Medical Officer
Limbix
Benjamin Alouf
Chief Medical Officer
Limbix
Sara Sarkey
Sara Sarkey
Chief Executive Officer
Digital Therapeutics Alliance
Sara Sarkey
Chief Executive Officer
Digital Therapeutics Alliance
Daniel Davgaard
Daniel Davgaard
Founder & Chief Executive Officer
Dawn Health
Daniel Davgaard
Founder & Chief Executive Officer
Dawn Health

Daniel Daugaard is the CEO and Founder of Dawn Health. Bringing sound experience from the Life Science Industry, Daniel founded Dawn Health in 2016, where the company has expanded at a rapid pace under his inspiring leadership, expertise and deep-rooted passion to change the lives of patients. 

 

In the past two years, he and the Dawn Health team have raised substantial investments, to deploy their product platform on a global scale and secured a board of directors consisting of the highest calibre leaders from the tech industry. Daniel has grown his team by 350% in 2022 and fostered new strong partnerships with the world’s leading pharma companies, through which Dawn Health provides DTx and SaMD products build from cutting-edge software, helping patients with chronic diseases to live better lives.

 

Daniel has successfully transformed his Danish-based company from a design and software powerhouse into a fully-fledged product company with a clear aim to accelerate the development of regulated software products leveraged by the Dawn Platform.

Amanda Way
Amanda Way
Principal
Jazz Venture Partners
Amanda Way
Principal
Jazz Venture Partners
Megan Jones Bell
Megan Jones Bell
Clinical Director, Consumer and Mental Health
Google
Megan Jones Bell
Clinical Director, Consumer and Mental Health
Google
Acacia Parks
Acacia Parks
Fractional Chief Science Officer
Found
Acacia Parks
Fractional Chief Science Officer
Found
Yusuf Sherwani
Yusuf Sherwani
Co-Founder & Chief Executive Officer
Quit Genius
Yusuf Sherwani
Co-Founder & Chief Executive Officer
Quit Genius
Patricia Bradley
Patricia Bradley
Chief Commercial Officer
MindMaze
Patricia Bradley
Chief Commercial Officer
MindMaze
Scott Snyder
Scott Snyder
Chief Digital Officer
EVERSANA
Scott Snyder
Chief Digital Officer
EVERSANA
Melinda Decker
Melinda Decker
Advisor and Fractional Chief Commercial Officer
Altoida
Melinda Decker
Advisor and Fractional Chief Commercial Officer
Altoida
Suhas Krishna
Suhas Krishna
Vice President, Head of Product Management, Digital Health
Bristol Myers Squibb
Suhas Krishna
Vice President, Head of Product Management, Digital Health
Bristol Myers Squibb
Amber Trivedi
Amber Trivedi
Chief Operating Officer
Blue Note Therapeutics
Amber Trivedi
Chief Operating Officer
Blue Note Therapeutics
David Matthews
David Matthews
Chief Growth Officer
BrightInsight
David Matthews
Chief Growth Officer
BrightInsight

David Matthews, PhD, has 15 years of experience in pharmaceuticals, medical technology, and medical research.

Before joining BrightInsight, David was a Partner in the Healthcare, Commercial, and Corporate Finance & Strategy Practices at Boston Consulting Group (BCG), where he helped lead the West Coast Medical Technology business. He served a range of healthcare clients on strategy, commercial, R&D, medical & regulatory affairs, and transformation topics, including standing up medical SaaS businesses. He was selected as an Ambassador to BCG’s internal thinktank, the Henderson Institute, where he designed and published on new economic models for biopharma products, including building the Netflix model for curative therapies. While at the firm, he received several internal awards and recognition for thought leadership, apprenticeship, and client success.

Prior to his time at BCG, David was a computational neuroscientist, with more than 20 publications and conference proceedings across machine learning, bioinformatics, brain imaging, neuroanatomy, and health economics. He has consulted independently on machine learning applications in biomedicine, built an early telemedicine app for automated melanoma detection, and taught neuroscience as an Adjunct Professor.

David holds a PhD in Computational Neurobiology from The University of California, San Diego and the Salk Institute, where he was a National Science Foundation (NSF) Research Fellow and NSF Center for Theoretical Biological Physics Fellow; and a Bachelor with honors in Molecular Biology, and minors in Bioengineering and Neuroscience, from Princeton University.

Steve Schwartz
Steve Schwartz
Head of Clinical Science & Innovation
Tridiuum
Steve Schwartz
Head of Clinical Science & Innovation
Tridiuum
Lani Hessen
Lani Hessen
Vice President of Patient Access
Digital Therapeutics Alliance
Lani Hessen
Vice President of Patient Access
Digital Therapeutics Alliance
Ricky Choi
Ricky Choi
Head of Digital Health
Samsung
Ricky Choi
Head of Digital Health
Samsung
Kristin Wynholds
Kristin Wynholds
Chief Product Officer
Better Therapeutics
Kristin Wynholds
Chief Product Officer
Better Therapeutics
Matthias Zenker
Matthias Zenker
Chief Medical Solutions Officer
GAIA
Matthias Zenker
Chief Medical Solutions Officer
GAIA
Laura Yecies
Laura Yecies
Chief Executive Officer
Bone Health Technologies
Laura Yecies
Chief Executive Officer
Bone Health Technologies
Joe Perekupka
Joe Perekupka
Chief Executive Officer
Freespira
Joe Perekupka
Chief Executive Officer
Freespira
Bilal Khan
Bilal Khan
Chief Financial Officer
Twill
Bilal Khan
Chief Financial Officer
Twill
Divya Shankar
Divya Shankar
Director of Program Management
Glooko
Divya Shankar
Director of Program Management
Glooko
John Drakenberg
John Drakenberg
Co-Founder & CEO
Alex Therapeutics
John Drakenberg
Co-Founder & CEO
Alex Therapeutics
Theo Ahadome
Theo Ahadome
Chief Business Officer
Wellthy Therapeutics
Theo Ahadome
Chief Business Officer
Wellthy Therapeutics
Whitney Stewart
Whitney Stewart
Director of Clinical Project Management
Curebase
Whitney Stewart
Director of Clinical Project Management
Curebase
Hillel Lehmann
Hillel Lehmann
Vice President, Transformation
Nestle Health Science
Hillel Lehmann
Vice President, Transformation
Nestle Health Science
Galym Imanbayev
Galym Imanbayev
Partner
Lightspeed Venture Partners
Galym Imanbayev
Partner
Lightspeed Venture Partners
Elise Vierra
Elise Vierra
Chief Creative Officer
Limbix
Elise Vierra
Chief Creative Officer
Limbix
Smit Patel
Smit Patel
Director of Digital Medicine | Program Lead
Digital Medicine Society
Smit Patel
Director of Digital Medicine | Program Lead
Digital Medicine Society
Danny Kim
Danny Kim
Head of WELT USA
WELT
Danny Kim
Head of WELT USA
WELT
Imein Bousnina
Imein Bousnina
Program Director, US Regulatory Policy
Genentech
Imein Bousnina
Program Director, US Regulatory Policy
Genentech
Craig Lund
Craig Lund
Chief Executive Officer & Co-Founder
Mightier
Craig Lund
Chief Executive Officer & Co-Founder
Mightier
Santosh Mohan
Santosh Mohan
Vice President of Digital
Moffitt Cancer Center
Santosh Mohan
Vice President of Digital
Moffitt Cancer Center
Jessica McKinney
Jessica McKinney
VP, medical Affairs and Clinical Advocacy
Renovia
Jessica McKinney
VP, medical Affairs and Clinical Advocacy
Renovia
Sarah Jackson
Sarah Jackson
Director of B usiness Development & Alliance Management
Click Therapeutics
Sarah Jackson
Director of B usiness Development & Alliance Management
Click Therapeutics
Brad Gescheider
Brad Gescheider
Chief Commercial Officer
Woebolt Health
Brad Gescheider
Chief Commercial Officer
Woebolt Health
Jamie Meyerson
Jamie Meyerson
Vice President, Provider Operations
Maven Clinic
Jamie Meyerson
Vice President, Provider Operations
Maven Clinic

Jamie’s goal is to help others lead healthier, happier lives through improving access to quality healthcare. She is currently working towards the latter as the Vice President, Network Strategy & Operations at Maven Clinic, scaling the largest virtual clinic for women’s and family health.

 

Prior to Maven, Jamie served in business development, operations, and service design roles at Mount Sinai Health Partners, focused on commercializing specialty care bundles and value-based care models. Jamie started her career as a management consultant within Deloitte’s Strategy & Operations practice, focused on product commercialization and growth strategy across the healthcare, materials science, and development sectors.

 

Jamie graduated magna cum laude as a Merrill Presidential Scholar from Cornell University and holds a Master of Business Administration from Columbia Business School.

Raj Pallapothu
Raj Pallapothu
Executive Chairman
Bio 9 Ventures
Raj Pallapothu
Executive Chairman
Bio 9 Ventures
Yuri Maricich
Yuri Maricich
Chief Medical Officer
Pear Therapeutics
Yuri Maricich
Chief Medical Officer
Pear Therapeutics

Dr. Maricich is a licensed, board-certified physician, investor, clinical developer, and strategist. He works
to improve patient health and our healthcare system by investing in, advising, and providing leadership
at innovative firms. At Pear Therapeutics, he leads the Clinical, Regulatory, and Quality groups as the
Chief Medical Officer and Head of Development. He leads and manages the development programs
from Discovery/TPP stage, through Translational, Clinical Development, Regulatory submission, and
review as well as Medical Affairs. In addition to overseeing subsequent pipeline programs across a
broad-spectrum of disease areas, he has led the reSET, reSET-O, and Somryst programs.
Prior to joining Pear, Dr. Maricich worked with and lead successful teams and programs at Healthcare &
Life Science/biotech (HLS) firms, including Corixa (acquired by GlaxoSmithKline), Xdynia (acquired by
Cavion), Cavion (acquired by Jazz Pharmaceuticals) and AWS. He founded a digital health firm while a
med student that used AI and NLP to structure clinical data.
Dr. Maricich completed his education and training at Harvard University, the University of Washington,
the University of Notre Dame, and the University of Virginia.

Alyssa Dietz
Alyssa Dietz
Senior Director, Precision Care Strategy
Twill
Alyssa Dietz
Senior Director, Precision Care Strategy
Twill
Hannes Klopper
Hannes Klopper
Chief Executive Officer & Co-Founder
HelloBetter
Hannes Klopper
Chief Executive Officer & Co-Founder
HelloBetter
Jenna Carl
Jenna Carl
Chief Medical Officer
Big Health
Jenna Carl
Chief Medical Officer
Big Health

Dr. Jenna Carl is a clinical psychologist who specializes in the research and treatment of anxiety, depression, insomnia, and related mental health disorders. She has authored more than 30 peer-reviewed publications, and has presented her research and clinical trainings at leading international conferences, such as the Association for Behavioral and Cognitive Therapies, World Congress for Behavioral and Cognitive Therapies, and the American Psychological Association (APA). She serves as Chair of the APA’s Division 12 Presidential Task Force on the integration of technology and mental health treatment.

As the Chief Medical Officer at Big Health, Dr. Carl is responsible for developing evidence-based digital therapeutics for common mental health conditions that can be implemented within large employers, health plans, and health systems. She obtained her PhD in clinical psychology from Boston University, with training in the Center for Anxiety and Related Disorders at Boston University, Massachusetts General Hospital, Harvard Medical School, and the VA Health System’s National Center for Innovation to Implementation.

Megan Coder
Megan Coder
Chief Policy Officer
Digital Therapeutics Alliance
Megan Coder
Chief Policy Officer
Digital Therapeutics Alliance
Ronen Jashek
Ronen Jashek
Co-Founder & Chief Operating Officer
Theranica
Ronen Jashek
Co-Founder & Chief Operating Officer
Theranica
Paul Strijbos
Paul Strijbos
Neurotech Innovation Leader
Roche
Paul Strijbos
Neurotech Innovation Leader
Roche
Jessica Lake
Jessica Lake
Chief Science Officer
Limbix
Jessica Lake
Chief Science Officer
Limbix
Athena Robinson
Athena Robinson
Chief Clinical Robinson
Woebot Health
Athena Robinson
Chief Clinical Robinson
Woebot Health
Adam Kaufman
Adam Kaufman
Former GM & SVP, Healthcare & Diabetes
Formally WW
Adam Kaufman
Former GM & SVP, Healthcare & Diabetes
Formally WW
Mathew Tucker
Mathew Tucker
Chief Commercial Officer
Nightware
Mathew Tucker
Chief Commercial Officer
Nightware
Jason Parent
Jason Parent
Director of Clinical Innovation
Point32Health
Jason Parent
Director of Clinical Innovation
Point32Health
Lily Tang
Lily Tang
Deputy Director Digital Investment Strategy
NHS
Lily Tang
Deputy Director Digital Investment Strategy
NHS
Jason Kahn
Jason Kahn
Chief Science Officer & Co-Founder
Mightier
Jason Kahn
Chief Science Officer & Co-Founder
Mightier
Neil Hattangadi
Neil Hattangadi
Chief Executive Officer
Cortica
Neil Hattangadi
Chief Executive Officer
Cortica
John Kutz
John Kutz
Managing Director
EVERSANA
John Kutz
Managing Director
EVERSANA
Vijay Ravindran
Vijay Ravindran
Chief Executive Officer
Floreo
Vijay Ravindran
Chief Executive Officer
Floreo
Andrzej Jonczyk
Andrzej Jonczyk
US CEO
Prosoma
Andrzej Jonczyk
US CEO
Prosoma

Partner with us

The DTx summits are the premier events for senior executives from DTx companies, Pharma, Policy Makers, Investors, HCPs and Payers.

DTx West 2023 is the twelth summit in the US DTx series.  We anticipate over 450 people in attendance, which is what our attendees and partners tell us is the optimum size.

We believe that getting the right mix of partners is critical for a successful summit for you and our attendees. The DTx summit provides a rare opportunity to showcase your business to a world-class audience.

You will be impressed with our service and truthfulness. We will be honest with you throughout the process from deciding which option is right for you to delivery on-site.

Get in touch today to learn more and avoid missing out!

Contact Us +
Partner with us

Register for the Event

For pricing and booking options please click the button to go to the registration page.

Registration